PRO MEDICUS LIMITED — Interim / Quarterly Report 2014

Feb 20, 2014

Appendix 4D Half-Year Report

Rule 4.2A

==> picture [113 x 30] intentionally omitted <==

Appendix 4D

Half-Year Report

1. Company details

Name of entity

1. Company detailsName of entity	1. Company detailsName of entity	1. Company detailsName of entity
Pro Medicus Limited
ABN or equivalentcompany reference25 006 194 752	Financial half year ended(‘current period’)31 December 2013	Financial half year ended(‘previous period’)
25 006 194 752	31 December 2013	31 December 2012

2. Results for announcement to the market.

The information in this report should be read in conjunction with the 30 June 2013 Annual Financial Report.

ASXListingRules**Ref **2.12.22.3		2013A$’000	2013A$’000	2012A$’000	2012A$’000	%change
	Revenue from ordinary activities	6,065		5,807		4.4%
	Underlying profit (net profit after taxminus one off contributions)Significant one off items (Sale ofAmira/Impairment)Profit/(Loss) from ordinary activitiesafter tax attributable to members	201-201		(628)5,3884,760		75.8%-(95.8%)
	Net Profit/(Loss) for the period attributable tomembers% change up/(down) of Net Profit/(Loss) for theperiod attributable to members from theprevious corresponding period.		201Down95.8%
2.4	Dividends (distributions)		Amount persecurity		Franked amountpersecurity
	Franked dividend amount per securityFinal DividendPrevious corresponding periodInterim DividendPrevious corresponding period		1.0 cents1.0 cents1.0 cents1.0 cents		1.0 cents1.0 cents1.0 cents1.0 cents
2.5	Record date for Interim dividend7 March 2014Interim dividends payment dates21 March 2014

Page 1

Appendix 4D Half-Year Report

==> picture [113 x 30] intentionally omitted <==

	Appendix 4DHalf-Year Report
2.6	REVIEW AND RESULTS OF OPERATIONSThe Company reported a first half after tax profit of $0.20M, an increase of $0.83Mcompared with the underlying result from operations (as defined by net profit after taxminus one off contributions) for the same period last year. This was due to a combinationof increased revenue which improved by 4.4% to $6.07M and a reduction in operatingcosts.After taking into account one off contributions in the previous corresponding period fromthe sale of the Amira business of $8.61M and the after tax impairment loss of $3.22M,net profit decreased by 95.8%.During the period, the company continued to make progress in North America winning anew contract with VISN 23, a division of the Veterans Affairs. Revenue from this contractis expected to commence in the second half of this financial year. The company alsosuccessfully implemented the first vRad installation in November with transaction basedrevenue from this contract commencing at that time.The Company is looking to build on its presence in North America and is activelypursuing a number of opportunities both within the private imaging center and largeteaching hospital markets.The Company continued its significant investment in R&D, both in Australia as well asoverseas. This has led to a number of enhancements to the existing product lines aswell as further progress with the company's new technology RIS platform, whichcontinued to be rolled out to new sites during the half year.Promedicus.net, the Company's e-health offering, continued to perform well throughoutthe period despite increasing competition.The Company's cash reserves remained high at $17.84M at the end of December 2013.It is estimated that approximately $4.0M of this will be used to pay tax on the profit of theAmira sale leaving the company with cash reserves of around $14M. The companyremains debt free.The Board is of the view that there are sufficient cash reserves to fund the anticipatedgrowth of the business from internal sources. As a result the company has announcedan interim dividend of 1.0c per share fully franked..
3.	Net Tangible Assets per security20132012Net Tangible Assets per security$0.13$0.15
4.	Details of entities over which control has been gained or lost during theperiodThere are no entities over which control has been gained or lost during the period.

Page 2

Appendix 4D Half-Year Report

==> picture [113 x 30] intentionally omitted <==

	5.	Details of Dividends
		Interim DividendAn Interim Dividend of 1.0 cents (2012: 1.0 cents) pershare fully franked will be paid on 21 March 2014.	2013$’000	2012$’000
			1,003	1,003
	6.	Dividend or Distribution reinvestment plansThere are no dividend or distribution reinvestment plans in operation.
	7.	Associates and joint venture entitiesThere are no associates or relevant joint ventures.
	8.	Foreign Entity accounting standardsNot applicable
	**9. **	Audit Statement
		This report is based on accounts to which one of the following applies.(Tick one)The+accountshavebeenaudited.The+accounts have been subject toreview.The+accountsareintheprocess of being audited orsubject to review.The+accounts have_not_ yet beenaudited or reviewed.

Sign here:

==> picture [99 x 70] intentionally omitted <==

Peter T Kempen Chairman

Date: 21[st] February 2014

Page 3